The tweet was deleted by the author.
But we saved everything 🙂.
CME Group reports that clients have traded over $456 million in notional volume during weekend sessions since the launch of 24/7 trading on May 29.
Trading activity involved more than 63,000 contracts in these weekend sessions. CME Group shared the update on social media.
CME Group ($246.38) trades well below its short-term (MA-20 at $264.88), medium-term (MA-50 at $280.45), and long-term (MA-200 at $281.68) moving averages, indicating sustained downside pressure across all timeframes. The Ichimoku Kijun level stands at $276.28, acting as immediate resistance above the current price. Near-term support is defined by MA-20 at $264.88, with key support at MA-50 around $280.45. On the resistance side, the Ichimoku Kijun at $276.28 marks the initial barrier, followed by MA-200 as key resistance at $281.68.
Momentum signals on D1 are negative, with both MACD and ADX confirming bearish strength. RSI and CCI readings suggest the stock is moving into oversold territory, while Stoch RSI adds a neutral tone. BBP values signal clear seller dominance, confirming strong downside momentum. The Awesome Oscillator also aligns with the bearish direction. In today's session, CME Group is under heavy pressure, dropping 2.44%. Over the past week, CME has fallen $23.15 (8.59%) from last week's close of $269.53, with the current price positioned at the very bottom of the weekly range. Weekly volatility stands at 9.68%, and the tone is a steady decline from the highs, confirming persistent selling.
For the coming week, the expected trading range is $244.50 to $254.60, anchored just above the 52-week low ($244.56) and well below the annual high ($329.16). There is a very low probability (less than 20%) of a sustained price rebound, making further declines more likely given the clear sell signals on MA-50, RSI, ADX, and MACD on W1. The baseline scenario calls for CME to consolidate within the $244.50–$254.60 corridor. If the price rallies above $254.60, a short-term recovery could target $261.50, but this is an unlikely scenario. A bearish break below $244.50 could open the way for new yearly lows, reflecting strong downside risks in the short term.
Earlier, analysts noted that CME Group was facing persistent bearish pressure, even as company leadership embarked on structural changes and introduced new products. In light of the current developments, investors should closely monitor whether recent shifts in sentiment or market structure could alter the prevailing downtrend or present an inflection point for the stock.